PRIA Logo™
116-hr-5133116th Congress

Affordable Prescriptions for Patients Through Promoting Competition Act of 2019

Sponsored By: Representative Cicilline, David N. [D-RI-1]

Unknown

Summary

Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 This bill prohibits, subject to certain exceptions, the practice of product hopping, which is presumed when a drug manufacturer obtains removal of a drug from the Food and Drug Administration's approved drug list, discontinues a drug, or markets a reformulation of an already approved drug during a certain period after which the manufacturer has been notified that a competing drug manufacturer has applied for generic drug approval.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Cicilline, David N. [D-RI-1]

RI • D

Cosponsors

  • Rep. Collins, Doug [R-GA-9]

    GA • R

    Sponsored 11/18/2019

  • Rep. Nadler, Jerrold [D-NY-12]

    NY • D

    Sponsored 11/18/2019

  • Rep. Sensenbrenner, F. James, Jr. [R-WI-5]

    WI • R

    Sponsored 11/18/2019

  • Rep. McBath, Lucy [D-GA-6]

    GA • D

    Sponsored 11/20/2019

  • Rep. Cline, Ben [R-VA-6]

    VA • R

    Sponsored 11/20/2019

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation